These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 8267671)

  • 21. Acute, subacute and chronic oral toxicity studies of the new serotonin (5-HT)3-receptor antagonist ramosetron in beagle dogs.
    Tabata H; Matsuzawa T; Hanada T; Ishikawa A; Yamada M; Ozaki H; Izumisawa N; Barker MH; Cox RA; Buist DP
    Arzneimittelforschung; 1995 Jul; 45(7):760-6. PubMed ID: 8573218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute, subchronic and chronic safety studies with genistein in rats.
    Michael McClain R; Wolz E; Davidovich A; Pfannkuch F; Edwards JA; Bausch J
    Food Chem Toxicol; 2006 Jan; 44(1):56-80. PubMed ID: 16213646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acylureidoalkylphenylsulfonylureas with blood glucose lowering efficacy.
    Weyer R; Hitzel V
    Arzneimittelforschung; 1988 Aug; 38(8):1079-80. PubMed ID: 3196400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Delayed sulfonylurea resistance in non-insulin-dependent diabetes mellitus].
    Farkas K; Jermendy G; Somogyi A
    Orv Hetil; 1997 Nov; 138(48):3031-5. PubMed ID: 9441264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NTP Toxicology and Carcinogenesis Studies of alpha-Methyldopa Sesquihydrate (CAS No. 41372-08-1) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1989 Mar; 348():1-184. PubMed ID: 12704436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formulation and biological evaluation of glimepiride-cyclodextrin-polymer systems.
    Ammar HO; Salama HA; Ghorab M; Mahmoud AA
    Int J Pharm; 2006 Feb; 309(1-2):129-38. PubMed ID: 16377107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics as an aid in the interpretation of toxicity tests.
    Hammer R; Boxler G
    Arzneimittelforschung; 1977; 27(3):555-7. PubMed ID: 577420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of fluconazole and fluvoxamine on the pharmacokinetics and pharmacodynamics of glimepiride.
    Niemi M; Backman JT; Neuvonen M; Laitila J; Neuvonen PJ; Kivistö KT
    Clin Pharmacol Ther; 2001 Apr; 69(4):194-200. PubMed ID: 11309547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Porin proteins in mitochondria from rat pancreatic islet cells and white adipocytes: identification and regulation of hexokinase binding by the sulfonylurea glimepiride.
    Müller G; Korndörfer A; Kornak U; Malaisse WJ
    Arch Biochem Biophys; 1994 Jan; 308(1):8-23. PubMed ID: 8311478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glypentide: a new hypoglycaemic agent.
    Morell J
    Biochem Pharmacol; 1974 Oct; 23(20):2922-4. PubMed ID: 4429592
    [No Abstract]   [Full Text] [Related]  

  • 32. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of the absolute bioavailability of glimepiride (HOE 490), a new sulphonylurea.
    Badian M; Korn A; Lehr KH; Malerczyk V; Waldhäusl W
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):481-2. PubMed ID: 1490793
    [No Abstract]   [Full Text] [Related]  

  • 34. [Glisolamide, a new sulfanylurea. Pharmacologic characteristics].
    D'Alò G; Dalla Vedova R; Cadel S; Campi G; Wassermann A
    Boll Chim Farm; 1978 Jun; 117(6):348-67. PubMed ID: 743381
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effectiveness, toxicity and action of new hypoglycemic agents].
    Wójcikowski C
    Pol Tyg Lek; 1978 Oct; 33(40):1583-4. PubMed ID: 704465
    [No Abstract]   [Full Text] [Related]  

  • 36. [Studies on subacute and chronic toxicity of butylmalonic acidmono-(1,2-diphenylhydrazide)calcium (bumadizone-calcium)].
    König J; Fenzki JE; Meier-Dörzenbach ED; Padberg G; Schäfer H
    Arzneimittelforschung; 1973 Sep; 23(9):1237-46. PubMed ID: 4801216
    [No Abstract]   [Full Text] [Related]  

  • 37. [A new highly-active oral antidiabetic].
    Aumüller W; Bänder A; Heerdt R; Muth K; Pfaff W; Schmidt FH; Weber H; Weyer R
    Arzneimittelforschung; 1966 Dec; 16(12):1640-1. PubMed ID: 6014800
    [No Abstract]   [Full Text] [Related]  

  • 38. [Differentiation between "specific" toxicity and "nonspecific" toxicity of different hypoglycemic drugs].
    Desplaces A; Jousse S
    Ann Pharm Fr; 1965 Jun; 23(6):411-8. PubMed ID: 5844390
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute, subchronic and chronic toxicity of the new sulfonylurea glimepiride in rats.
    Donaubauer HH; Mayer D
    Arzneimittelforschung; 1993 May; 43(5):547-9. PubMed ID: 8328999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subchronic and chronic toxicity of the new sulfonylurea glimepiride in dogs.
    Schollmeier U; Brunk R; Mayer D
    Arzneimittelforschung; 1993 Oct; 43(10):1068-71. PubMed ID: 8267671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.